Mitral stenosis prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "_NOTOC__ {{Mitral stenosis prevention}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no availa...") |
|||
Line 1: | Line 1: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever. | |||
<br /> | |||
==Primary Prevention== | ==Primary Prevention== |
Revision as of 14:08, 10 April 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Effective measures for the primary prevention of mitral stenosis include preventing of endocarditisa and decreasing new patients of rheumatic fever.
Primary Prevention
There are no established measures for the primary prevention of [disease name].
OR
There are no available vaccines against [disease name].
OR
Effective measures for the primary prevention of [disease name] include:
- [Measure1]
- [Measure2]
- [Measure3]
OR
[Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]